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ABSTRAK
Tujuan: mendapatkan kesintasan dan faktor-faktor yang berhubungan dengan mortalitas pada pasien ikterus 
obstruktif dengan etiologi maligna. Metode: penelitian kohort retrospektif dan prospektif dilakukan dengan data 
sekunder pasien ikterus obstruktif yang dirawat di RS. Cipto Mangunkusumo, Jakarta antara Januari 2010–
Desember 2013. Faktor-faktor yang dinilai meliputi umur, jenis kelamin, sepsis, hipoalbumin, tingkat bilirubin 
serum, tingkat CA 19-9 serum, drainase bilier, keganasan non ca ampula Vater, dan komorbid dengan hasil keluaran 
berupa mortalitas pasien. Hasil: sebanyak 181 dari 402 pasien ikterus obstruktif dengan etiologi maligna memenuhi 
kriteria penelitian dengan proporsi laki-laki sebesar 58,6 % dengan  pasien berumur ≥50 tahun sebesar 57,5%. 
Analisis multivariat menunjukkan bahwa sepsis, riwayat drainase bilier sebelumnya dan skor komorbid Charlson ≥4 
merupakan prediktor independen terhadap mortalitas. Median kesintasan pasien dengan faktor prognosis bermakna 
adalah 14 hari sedangkan median kesintasan keseluruhan 26 hari. Ambang skor prognostik terbaik didapatkan 
pada skor ≥2 dengan sensitivitas 68% dan spesifisitas 75%. AUC pada kurva ROC 0.769. Kesimpulan: kesintasan 
pasien dengan faktor prognosis sepsis, drainase bilier tidak berhasil/tidak ada, dan skor indeks komorbid Charlson 
≥4 lebih pendek dibandingkan kesintasan keseluruhan pasien. Skor prognostik ≥2 termasuk dalam risiko tinggi 
kematian dan kemampuan prediksi mortalitas dari faktor prognosis bermakna adalah 76.9%.
Kata kunci: ikterus obstruktif maligna, kesintasan, mortalitas, faktor prognosis, skor prognosis.
ABSTRACT
Aim: to obtain survival rate and mortality-related factors of malignant obstructive jaundice patients. 
Methods: all medical records of obstructive jaundice inpatient at Cipto Mangunkusumo Hospital, Jakarta from 
January 2010 to December 2013 were reviewed retrospectively. The following factors were analyzed in terms 
of mortality: age, gender, sepsis, hypoalbumin, serum bilirubin level, serum CA 19-9 level, billiary drainage, 
non-ampulla Vateri carcinoma, and comorbid factors. Results: total 181 out of 402 patients were enrolled in this 
study with male proportion was 58.6%, and patients aged 50 years or above was 57.5%. Multivariate analysis 
showed that only sepsis, unsuccessful or no prior biliary drainage and Charlson comorbid score ≥4 were 
independent predictors of mortality. Patients with significant prognostic factors had median survival 14 days 
compared with overall median survival 26 days. Score ≥2 identified as the highest prognostic score threshold with 
sensitivity 68%, specificity 75%, and AUC on ROC curve 0.769. Conclusion: sepsis, unsuccessful or no prior 
bilirary drainage, and Charlson comorbid score ≥4 are factors significantly associated with shortened survival 
in malignant obstructive jaundice patients. Prognostic score  ≥2 was determined to classify patients into high 
risk mortality group. Mortality of patients with those significant prognostic factors can be predicted in 76.9%.
Keywords: malignant obstructive jaundice, survival, mortality, prognostic factors, prognostic score.
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INTRODUCTION
Most malignant tumors causing obstructive 
jaundice have poor prognosis, such as pancreas 
cancer, cholangiocarcinoma, gall bladder cancer, 
and etc. At time of diagnosis, the majority of the 
tumors already present distant metastases. For 
example, pancreas cancer has very poor prognosis 
with median survival of 2 to 6 months after stage 
4 diagnosis. Data from Cipto Mangunkusumo 
National General Hospital, Jakarta show an 
increase in obstructive jaundice with malignant 
etiology along with an increase in drainage 
procedures including percutaneous transbiliary 
drainage (PTBD), endoscopic retrograde 
cholangio-pancreaticography (ERCP).1
There are several available reports on 
identification of mortality related factors in 
patients with obstructive jaundice. Age and 
gender2, sepsis3, bilirubin levels4, CA 19-95, 
albumin levels6, drainage procedures7 and 
comorbid diseases8 were considered as related 
factors. Up to date, there are no available limited 
studies yet in Indonesia to analyze association 
between mortality related factors and survival 
rate in obstructive jaundice specifically with 
malignant etiology.
Mortality of obstructive jaundice depends on 
the cause of obstruction. Most common cause 
of obstructive jaundice is different for every 
population, therefore assessment of any mortality 
related factors, especially in each population, is 
necessary. The aim of this study is to find out the 
3 months-survival rate, mortality related factors 
and prognostic scoring in malignant obstructive 
jaundice patients. The outcome of this study is to 
optimalize the patients’ management to improve 
survival and quality of life.
METHODS
This study has been approved by The Ethics 
Committee of the Faculty of Medicine, University 
of Indonesia, with registry number 525/H2.F1/
ETIK/2013. Our institutional database were 
retrospectively searched for the records of 
obstructive jaundice inpatients aged 18 years 
or older with malignant etiology who had been 
hospitalized in Cipto Mangunkusumo Hospital 
from January 2010 to February 2014. Seven 
hundred fifty eight patients were hospitalized in 
Cipto Mangunkusumo Hospital from January 
2010 to February 2014 with 402 among them 
have malignant etiology. As many as 221 
subjects were excluded due to the incomplete 
data regarding mortality related factors. One 
hundred eighty one patients were enrolled in 
this study, following the minimum number of 
subjects required.
Clinical and Laboratory Parameters
Nine potential predictive factors were 
studied: age, gender, sepsis, albumin levels, 
bilirubin levels, CA 19-9 levels, unsuccessful 
or no history of biliary drainage and Charlson 
comorbid index score. All malignant tumors 
found in the ampulla of Vater, pancreas, biliary 
duct, and liver were included in the study after 
confirmation through upper gastrointestinal 
endoscopy, abdominal ultrasonography and/or 
CT scan and/or MRI and/or cholangiography.
Obstructive jaundice was defined as an 
elevation in serum bilirubin levels. Initially, an 
increase in conjugated bilirubin levels occurs 
without affecting unconjugated bilirubin levels 
with a finding of mechanical obstruction. 
Age and gender of the patients were obtained 
according to patients’ identity card. Sepsis was 
defined according to American College of Chest 
Physician/Society of Critical Care Medicine 
1992 criteria; body temperature >38oC or <36 
oC, heart rate >90 beats per minute, respiratory 
rate >20 breaths per minute or PaCO2 <32 
mmHg and leukocyte levels >12.000/mm3 or 
<4.000/mm3 with evidence of focal infection. 
Charlson Comorbid Index was used to calculate 
comorbid score for each patient.
Laboratory parameters include albumin, 
bilirubin and CA 19-9, were measured on the first 
day of admission. Albumin levels below 3.0 g/dl 
was defined as hypoalbuminemia. High bilirubin 
was defined if bilirubin ≥15 mg/dl. High CA 19-9 
levels was defined as levels ≥100 U/ml.
Biliary Drainage
Biliary drainage had been performed through 
PTBD, ERCP, and/or biliodigestive bypass 
surgery. Drainage procedure was considered 
success if a minimal 2 mg/dl bilirubin serum 
decreased after 2 to 5 days post drainage. Patients 
were divided into two groups: first group with 
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history of biliary drainage procedure and the 
second group with unsuccessful or no history of 
biliary drainage.
Survival
Follow up for assessment of survival was 
done by phone calls after the study subjects’ 
death. If the patient was unreachable via phone 
call, we did a home visit to the patients’ registered 
adress.
Statistical Analysis
All numerical data were presented as mean 
with standard deviation or median with range. 
Cumulative three-month survival was measured 
from the date of diagnosis of obstructive jaundice 
with malignant etiology and calculated by 
the methods of Kaplan-Meier. Bivariate and 
multivariate analyses were performed using Cox 
Proportional Hazards Regression Model. Each 
of the predictors was transformed into covariate 
to mortality outcome in bivariate analysis 
by considering occurrence time of mortality. 
Predictors that were deemed of potential 
importance on the bivariate analysis (P<0.2) 
were included in multivariate analysis of these 
factors. P<0.05 was regarded as significant.
From each significant prognostic factor, 
a prognostic score was determined from the 
last regression model. Sensitivity, specificity, 
positive predictive value and negative predictive 
value were calculated according to considered 
relevant cut-off value. Receiver Operating 
Characteristic (ROC) curve was generated 
and Area Under Curve (AUC) was calculated 
using predictive probability from every subject 
that decided based on last regression model to 
mortality outcome. All statistical analyses were 
performed with SPSS for mac version 22.0.
RESULTS
During the period between January 2010 
and February 2014, a total of 759 obstructive 
jaundice patients were hospitalized of whom 
402 patients had bile duct obstruction due to 
malignant etiology. Total 181 patients were 
enrolled according to inclusion and exclusion 
criteria related to the completion of data. Among 
the subjects, 58.6% were men and men to women 
ratio was 1.42 with majority of all patients were 
aged 50 years and older. The most common 
etiological factor of malignant obstructive 
jaundice was carcinoma of the head of pancreas. 
There were 24 patients (13.3%) in stage 4 of 
the disease while 148 patients (81.6%) have 
insufficient staging data. Detailed characteristics 
of all patients are summarized in Table 1.
Table 1. Subject’s characteristics
Variables Values
Gender (Male), n (%) 106 (58.6)
Age (years), median (range) 52 (18.86)
Age (years), n (%)
 - <50 77 (42.5)
 - ≥50 104 (57.5)
Cancer, n (%)
 - Ampulla of vater cancer 31 (17.1)
 - Non ampulla of vater cancer :
 - Head of pancreas cancer 101 (55.8)
 - Cholangiocarcinoma 35 (19.3)
 - Lymphoma 3 (1.7)
 - Gall bladder cancer 1 (0.6)
 - Hepatocellular carcinoma 8 (4.4)
 - Gastric cancer 1 (0.6)
 - Metastatic colon cancer 1 (0.6)
 - Staging
 - 1: gall bladder cancer 1 (0.6)
 - 2: gastric cancer 1 (0.6)
 - 3: cholangiocarcinoma, head of 
pancreas cancer, hepatocellular 
carcinoma
7 (3.9)
 - 4: metastatic colon cancer, 
cholangiocarcinoma, head of 
pancreas cancer, hepatocellular 
carcinoma
24 (13.3)
 - Data not available 148 (81.6)
From the laboratory results, most of the 
subjects have increased serum AST and ALT 
levels with median of 103.5 IU/L and 66.5 IU/L, 
respectively. Median value of ureum is 26.4 mg/
dL and creatinine is 0.7 mg/dL. Mean of albumin 
levels is 2.86 g/dL with 61.9% subjects have 
albumin <3.0 g/dL. There were 68.2% subjects 
with CA 19-9 levels ≥100 U/mL with overall 
median of 390.2 U/mL. Baseline bilirubin level 
≥15 mg/dL was found in 66.7%.  Biliary drainage 
was performed in all subjects and 64.1% of 
whom have shown successful result. Charlson 
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comorbidity index score <4 was seen in majority 
of subjects (72.4%). Overall 3-month mortality 
was 55.2% with cumulative survival of 27.7% 
(SE 4.2%) and median survival of 26 days (SE 
2.65 days, 95% CI 20.82 – 31.19). From bivariate 
analysis, all factors except gender, age and CA 
19-9 levels were associated with mortality in 
malignant obstructive jaundice patients.
Of all the remaining prognostic factors 
evaluated, only those significantly affecting 
survival have been listed in Table 2. Multivariate 
analysis demonstrated that sepsis, unsuccessful 
or no history of biliary drainage and Charlson 
comorbid index score ≥4 were independent 
negative prognostic factors.
The overall median survival was 26 days 
(95% CI 20.82–31.19) and was significantly 
higher for patients without prognostic factors 
than with prognostic factors (median 14 days, 
95% CI 9.66–18.34) as shown in Figure 1. 
According to biliary drainage procedure, there 
were slightly different of median survival in 
patients with palliative surgery and ERCP/PTBD 
drainage (median 32 days, SE 55.43 and median 
30 days, SE 4.3, respectively). Survival improved 
when palliative drainage was performed after 
prior ERCP/PTBD with median survival of 450 
days, SE 317.91. Shortened median survival 
was shown in patients with sepsis, unsuccessful 
or without prior biliary drainage and Charlson 
comorbid index score ≥4 (17 days SE 1.90, 15 
days SE 2.68, 16 days SE 4.37, respectively).
Three of the significant prognostic factors 
were later then included in the last regression 
model to determine prognostic score (Table 3). 
Score ≥2 has good sensitivity and specificity 
with PPV 98.6%. Hosmer-Lemeshow test was 
done to predict discrimination power of the 
prognostic score and resulted with P-value of 
0.872. Discrimination power of the scoring 
system in predicting three-month mortality is 
Table 2. Multivariate analysis of prognostic factors
Risk factors HR (95% CI) p
Sepsis 2.462 (1.552-3.906) <0.001
Hypoalbuminemia 1.275 (0.808-2.013) 0.297
Non ampulla of Vater 
cancer 1.622 (0.886-2.967) 0.117
Baseline bilirubin level 
≥15 mg/dl
1.604 (0.988-2.603) 0.056
Unsuccessful or no 




index score ≥4 1.478 (1.117-2.735) <0.001
Figure 1. Comparison of survival in malignant obstructive 
jaundice patients related to significant prognostic factors.
moderately good with AUC 0.769, 95% CI 
0.668–0.871 (Figure 2).
DISCUSSION
In this study, nine factors were studied and 
three factors were significantly correlated with 
mortality of malignant obstructive jaundice 
patients: sepsis, unsuccessful or no history of 
biliary drainage and Charlson comorbid index 
score ≥4. Obstructive jaundice occurred almost 
Table 3. Multivariable of mortality prognosis factors in malignant obstructive patients
Prognostic factors coefficient (β) SE β/SE Score Round up scoring
Sepsis 0,901 0,235 3,83 1,57 2
Unsuccessful or no biliary drainage 0,907 0,235 3,86 1,58 2
Charlson comorbidity index score ≥4 0,558 0,229 2,44 1 1
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similarly in both genders with slightly higher in 
male than female. Majority of the cases were 
found in patients aged ≥50 years. A study by 
Moghimi et al.2 found the male to female ratio 
was 1.14 and the mean age was 66.58±12.13. In 
this study, neither gender nor age was statistically 
correlated with mortality, similar with several 
other studies.2,9,10
Prevalence of obstructive jaundice in both 
genders depends on the disease etiology. In 
another study2, carcinoma of the head of pancreas 
was commonly found as the cause of obstructive 
jaundice in males while gall bladder carcinoma 
more common in females, similar to our study. 
Different result showed in a study by Chalya et 
al.3 found that age was correlated with mortality. 
Similar result was also found by Pitiakoudis et 
al.11
Albumin was statistically insignificant 
related to mortality in this study, in contrast to 
several previous studies.11-13 Levels of CA 19-9 
was also an insignificant factor as shown as other 
studies.14,15 In contrast to our result, Ballehaninna 
et al.16 found that preoperative serum of CA 19-9 
<100 U/mL lead to better survival.
As concluded in prior studies,2,3,11 sepsis 
was also significantly correlated with mortality 
in our study. Jaundice was caused by sepsis and 
bacterial infection in 20% of cases, as a result 
of immune response, bacterial products or 
combination of both. Endotoxemia and release 
of mediators of inflammation in response to 
infection were the highlights of cholestasis 
pathophysiology in sepsis. Inflammatory 
response and cytokines cascade promote vascular 
dysfunction through increase in permeability 
and vasodilatation that result in hypotension and 
disseminated intravascular coagulation. Those 
mechanisms lead to cellular hypoxia and lactate 
acidosis that potentially cause multiple organ 
dysfunction and death.12,13
Biliary drainage was thought as an important 
step in reducing bilirubin levels and giving 
more chances for patients to receive additional 
therapy, including surgery, chemotherapy and 
focus therapy. Obstructive jaundice damage the 
tissue due to the release of various inflammatory 
mediators including oxygen free radicals. A 
deleterious effect of inflammatory mediators 
cause damage to hepatic sinusoidal endothelium 
and liver function. High concentration of bilirubin 
is also associated with the impaired healing. In 
our study, unsuccessful biliary drainage was 
statistically correlated with mortality as found in 
several studies.14,15 Contradictory to our studies, 
Choi et al.19 found no significant differences with 
bilirubin decrease and possible complications of 
the patient as well as in meta analysis of 1826 
subjects from 14 studies.17
Moreover, we found no significant difference 
in survival of patients with palliative drainage 
surgery and patients with ERCP/PTBD procedure. 
On the other hand, improved survival was shown 
in patients with prior ERCP/PTBD regardless 
type of procedure before palliative drainage 
surgery. Time to drainage since patient was 
admitted might be considered as a confounding 
factor that possibly explain the different result 
concluded in the several studies including ours. 
Comorbid diseases found to be statistically 
significant to mortality in our study. Mario et 
al.21 with lower score cut off showed similar 
result. Finally, the mortality rate of malignant 
obstructive jaundice patients in our study was 
lower than that of previous studies.22-24 Different 
prognostic factors and patients characteristic 
might play a part in generating different result 
from each study. 
The prognostic score was generated according 
to last regression model from cox proportional 
hazards regression by including three significant 
Figure 2. ROC curve of significant prognostic factors to 
mortality in malignant obstructive jaundice patients.
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prognostic factors. Curve of ROC and AUC 
showed predictive ability of prognostic factors. 
We found AUC of 0.769 which means that 
combining all prognostic factors can predict 
76.9% of mortality in malignant obstructive 
jaundice patients.
In summary, according to our results, 
sepsis, unsuccessful or no biliary drainage and 
Charlson comorbid index score ≥4 were all 
related to mortality in malignant obstructive 
jaundice patients. Prognostic score ≥2 was 
considered moderately good in categorizing 
patients based on the mortality risk. Further 
research is suggested to analyze other possible 
factors related to mortality and survival includes 
prothrombin time, Child Pugh score, disease 
staging and nutritional status of patients.
CONCLUSION
Sepsis, unsuccessful or no prior bilirary 
drainage, and Charlson comorbid score ≥4 are 
factors significantly associated with shortened 
survival in malignant obstructive jaundice 
patients. Prognostic score ≥2 was determined to 
classify patients into high risk mortality group. 
Mortality with those significant prognostic 
factors can be predicted in 76,9% of patients 
with obstructive jaundice.
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